(Q35197692)

7 August 2017

1 reference

title

Alzheimer's disease: the pharmacological pathway (English)

1 reference

7 August 2017

0 references

4

Serge Gauthier

1 reference

7 August 2017

Hervé Allain

1

1 reference

7 August 2017

Danièle Bentué-Ferrer

2

1 reference

7 August 2017

Olivier Tribut

3

1 reference

7 August 2017

Bernard-François Michel

5

1 reference

7 August 2017

Christophe Drieu-La Rochelle

6

1 reference

7 August 2017

1 August 2003

1 reference

Fundamental and Clinical Pharmacology

7 August 2017

1 reference

7 August 2017

17

1 reference

7 August 2017

419-428

1 reference

7 August 2017

4

1 reference

Drugs for Alzheimer's disease

7 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Pharmacotherapy for Alzheimer's disease: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Alzheimer's disease: current and future therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Effective decision-making: progressing compounds through clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

An fMRI investigation of emotional engagement in moral judgment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

The role of excitotoxicity in neurodegenerative disease: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Neuroprotective effects of lithium in cultured cells and animal models of diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

A unifying hypothesis of Alzheimer's disease. III. Risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

High-dose estradiol improves cognition for women with AD: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Advances and challenges in the prevention and treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Can estrogen or selective estrogen-receptor modulators preserve cognitive function in elderly women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Estrogen and cognitive aging in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Dopamine and the regulation of cognition and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Postsynaptic signaling and plasticity mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

A possible role for cholinergic neurons of the basal forebrain and pontomesencephalon in consciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Acetylcholine, aging, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Nicotinic receptors in the brain. Links between molecular biology and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Overview of nicotinic receptors and their roles in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Solid-phase synthesis and pharmacological evaluation of analogues of PhTX-12-A potent and selective nicotinic acetylcholine receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Neuroscience. New leads on the 'how' of Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

c-Jun mediates axotomy-induced dopamine neuron death in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Calpain and caspase: can you tell the difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Temporal relationships between de novo protein synthesis, calpain and caspase 3-like protease activation, and DNA fragmentation during apoptosis in septo-hippocampal cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

The mitochondrion: is it central to apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

A vertebrate globin expressed in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Overview and perspective on the therapy of Alzheimer's disease from a preclinical viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Is an effective immune intervention for Alzheimer's disease in prospect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

A portrait of Alzheimer secretases--new features and familiar faces

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Cerebral hemorrhage after passive anti-Abeta immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Chaperoning brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

A transmembrane form of the prion protein in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Alzheimer's disease. Bad for the heart, bad for the mind?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Ammonia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Proteomics of multiprotein complexes: answering fundamental questions in neuroscience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Neurobiology. Dopamine's reversal of fortune

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Toxic proteins in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Neurodegeneration. A glutamine-rich trail leads to transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

Biochemistry. Intramembrane proteases--mixing oil and water

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00153.X

10.1046/J.1472-8206.2003.00153.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference